Bristol-Myers Squibb buy The Goldman Sachs Group, Inc.
Start price
30.10.23
/
50%
€48.25
Target price
30.10.24
€65.03
Performance (%)
0.64%
End price
31.10.24
€48.56
Summary
This prediction ended on 31.10.24 with a price of €48.56. During the runtime of the prediction for Bristol-Myers Squibb the price only changed by 0.64%. Dividends of €2.20 are taken into consideration when calculating the performance. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | -5.231% | -5.231% | -1.612% |
| iShares Core DAX® | 0,23 % | -2,41 % | 15,34 % |
| iShares Nasdaq 100 | 1,66 % | -1,66 % | 31,09 % |
| iShares Nikkei 225® | -0,21 % | -2,50 % | 43,63 % |
| iShares S&P 500 | 1,07 % | -1,58 % | 24,35 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $81.00 to $69.00. They now have a "buy" rating on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten